Amid back to school season, companies were back to making diagnostic deals. Here's a recap of the key activity from mid-August through the third week of September. M&A and Asset Sales This … [Read more...]
ACQUISITIONS
Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month
October 15, 2018
NEW PRODUCTS
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
October 9, 2018
After a slow August, product launches were up in volume but not dramatic impact. Here's a rundown of the new diagnostics to hit the market in September. NEWLY LAUNCHED PRODUCTS & … [Read more...]
FALSE CLAIMS
The End Comes for Theranos
October 2, 2018
Just five years ago, Theranos was a Silicon Valley sensation with a valuation of over $9 billion. While black-turtlenecked Elizabeth Holmes supplied the charisma, the heart of the Theranos phenomenon … [Read more...]
INDUSTRY BUZZ
FDA Watch: New LDT Proposal Is Much Different from One Negotiated with Industry
October 2, 2018
The lab industry played an active role in the drafting of the Diagnostic Accuracy and Innovation Act (DAIA), a bill designed to establish a new regulatory regime for laboratory developed tests (LDTs). … [Read more...]
HEALTH CARE REFORM
Latest Legal Challenge to ACA May Mean a Hot Mess for Insurance Markets
October 2, 2018
After a series of setbacks, Republicans challenging the constitutionality of the Affordable Care Act (ACA) and its individual mandate are back at it. And this time they may win. Here's a look at the … [Read more...]
TECHNOLOGY
Artificial Intelligence: An Automated New World for Labs & Pathology
October 1, 2018
Artificial intelligence (AI) and machine learning are making significant inroads in the diagnostics realm. Here are four ways the technology is changing the field and the business of pathology. 1. … [Read more...]
PUBLIC HEALTH
Toxicology Laboratories Play Key Role in Curbing the Drug Addiction and Opioid Epidemic
September 24, 2018
The National Independent Laboratory Association's (NILA's) Opioid Task Force is releasing a white paper entitled Curbing Drug Addiction and the Opioid Crisis: The Role of Toxicology Laboratories in … [Read more...]
NEW PRODUCTS
The Dx Pipeline: A Roundup of the Month’s Key New Product Launches
September 14, 2018
After a busy July, the pace and volume of new product launches slowed significantly in August. NEWLY LAUNCHED PRODUCTS & SERVICES Company(ies) Product(s) HTG Molecular … [Read more...]
NEW PRODUCTS
FDA Watch: Lab Industry Objects to Agency’s New LDT Proposal
September 10, 2018
On Aug. 3, the Food and Drug Administration heated the long simmering controversy over FDA regulation of laboratory developed tests (LDTs) to full boil by submitting a new proposal to Congress, … [Read more...]
REVENUES
DX Earnings Report: Q2 Lab Earnings Stay Strong but Not Quite at Q1 Levels
September 4, 2018
Q2 is shaping up to be another strong quarter—albeit not as stellar as Q1. Salient trends: Big labs continue posting impressive organic growth even as they enjoy the surge of new revenues from … [Read more...]
